Coordinatore | TECHNISCHE UNIVERSITAET MUENCHEN
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
Nazionalità Coordinatore | Germany [DE] |
Totale costo | 1˙994˙000 € |
EC contributo | 1˙994˙000 € |
Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | ERC-2009-StG |
Funding Scheme | ERC-SG |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-01-01 - 2014-12-31 |
# | ||||
---|---|---|---|---|
1 |
TECHNISCHE UNIVERSITAET MUENCHEN
Organization address
address: Arcisstrasse 21 contact info |
DE (MUENCHEN) | hostInstitution | 1˙994˙000.00 |
2 |
TECHNISCHE UNIVERSITAET MUENCHEN
Organization address
address: Arcisstrasse 21 contact info |
DE (MUENCHEN) | hostInstitution | 1˙994˙000.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'In conventional x-ray imaging, contrast is obtained through the differences in the absorption cross-section of the constituents of the object. The technique yields excellent results where highly absorbing structures such as bones are embedded in a matrix of relatively weakly absorbing material, for example the surrounding tissue of the human body. However, in cases where different forms of tissue with similar absorption cross-sections are under investigation (for example, in mammography or neurology), the x-ray absorption contrast is relatively poor. Consequently, differentiating pathologic from non-pathologic tissue in an absorption radiograph obtained with a current hospital-based x-ray system remains practically impossible for certain tissue compositions. The goal of this research project is to overcome these limitations by developing and applying the potential of x-ray phase-contrast imaging for pre-clinical, biomedical x-ray imaging applications. The anticipated results of this project shall provide the scientific basis for future routine exploitation of biomedical x-ray phase contrast imaging through academic research and biomedical imaging device manufacturers. While I envision that the method will ultimately be applicable and beneficiary for several x-ray medical diagnostics applications (i.e., including computer tomography on humans), this project will focus on the first successful implementation of x-ray phase-contrast bioimaging for pre-clinical, small-animal applications.'